He cited the ASCO guidelines on hormonal therapy that stated that there is a 15-17% cancer specific survival, but is no overall survival benefit.

• 他引用了美国临床肿瘤学会激素治疗指南，其中提及仅有15-17%25癌症相关生存率但没有总生存期获益。